COSSIGA, VALENTINA
 Distribuzione geografica
Continente #
AS - Asia 1.930
NA - Nord America 1.640
EU - Europa 1.098
SA - Sud America 274
Continente sconosciuto - Info sul continente non disponibili 59
AF - Africa 49
OC - Oceania 6
Totale 5.056
Nazione #
US - Stati Uniti d'America 1.567
SG - Singapore 802
RU - Federazione Russa 572
CN - Cina 437
VN - Vietnam 353
BR - Brasile 227
IT - Italia 165
DE - Germania 101
HK - Hong Kong 101
FR - Francia 62
GB - Regno Unito 53
JP - Giappone 48
NL - Olanda 48
IN - India 39
KR - Corea 39
CA - Canada 36
BD - Bangladesh 28
CI - Costa d'Avorio 19
AR - Argentina 17
MX - Messico 16
FI - Finlandia 15
PL - Polonia 14
ZA - Sudafrica 14
UA - Ucraina 12
PH - Filippine 11
ES - Italia 10
ID - Indonesia 10
IQ - Iraq 10
EC - Ecuador 9
TH - Thailandia 9
AT - Austria 8
LT - Lituania 7
SE - Svezia 7
TR - Turchia 7
IE - Irlanda 6
VE - Venezuela 6
CL - Cile 5
HN - Honduras 5
PK - Pakistan 5
AE - Emirati Arabi Uniti 4
JM - Giamaica 4
JO - Giordania 4
PE - Perù 4
RO - Romania 4
AM - Armenia 3
AZ - Azerbaigian 3
BE - Belgio 3
CO - Colombia 3
EG - Egitto 3
KE - Kenya 3
PY - Paraguay 3
SA - Arabia Saudita 3
AL - Albania 2
AU - Australia 2
CH - Svizzera 2
CR - Costa Rica 2
CY - Cipro 2
CZ - Repubblica Ceca 2
ET - Etiopia 2
GT - Guatemala 2
LC - Santa Lucia 2
LV - Lettonia 2
MA - Marocco 2
NI - Nicaragua 2
NZ - Nuova Zelanda 2
TW - Taiwan 2
UZ - Uzbekistan 2
BG - Bulgaria 1
BN - Brunei Darussalam 1
CU - Cuba 1
CW - ???statistics.table.value.countryCode.CW??? 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
HR - Croazia 1
IL - Israele 1
KH - Cambogia 1
KZ - Kazakistan 1
ML - Mali 1
MY - Malesia 1
MZ - Mozambico 1
NG - Nigeria 1
NP - Nepal 1
OM - Oman 1
PF - Polinesia Francese 1
PG - Papua Nuova Guinea 1
PR - Porto Rico 1
PS - Palestinian Territory 1
PT - Portogallo 1
SV - El Salvador 1
TN - Tunisia 1
ZM - Zambia 1
Totale 4.998
Città #
Singapore 437
San Jose 286
Hefei 192
Ashburn 138
Moscow 137
Ho Chi Minh City 102
Hong Kong 97
Beijing 94
Hanoi 69
Santa Clara 68
Lauterbourg 42
Tokyo 42
Chandler 41
Los Angeles 41
Amsterdam 38
Seoul 35
New York 34
Naples 33
The Dalles 31
Buffalo 22
Frankfurt am Main 22
Munich 22
Düsseldorf 20
São Paulo 20
Council Bluffs 19
Kochi 17
Da Nang 16
Dallas 16
Chicago 15
Redondo Beach 15
Atlanta 14
Orem 14
London 13
Millbury 13
Toronto 13
Haiphong 12
Warsaw 12
Helsinki 11
Mexico City 10
Milan 10
Poplar 10
Brooklyn 9
Lawrence 9
Nuremberg 9
Denver 8
Des Moines 8
Manchester 8
Montreal 8
Can Tho 7
Jacksonville 7
Johannesburg 7
Napoli 7
Rio de Janeiro 7
San Francisco 7
Stockholm 7
Turin 7
Bangkok 6
Biên Hòa 6
Boston 6
Falkenstein 6
Hải Dương 6
Phoenix 6
Porto Alegre 6
Vienna 6
Ankara 5
Chennai 5
Dublin 5
Ninh Bình 5
Portsmouth 5
Rome 5
Seattle 5
Afragola 4
Baghdad 4
Baronissi 4
Brasília 4
Dong Ket 4
Guayaquil 4
Houston 4
Memphis 4
Mumbai 4
Newark 4
Philadelphia 4
Rochdale 4
Santa Maria La Carità 4
Thái Nguyên 4
Tân Tiến 4
Amman 3
Bologna 3
Brussels 3
Cairo 3
Caivano 3
Cape Town 3
Capodrise 3
Contagem 3
Curitiba 3
Jeddah 3
Joinville 3
Jundiaí 3
Las Vegas 3
Legnaro 3
Totale 2.593
Nome #
The combination of berberine, tocotrienols and coffee extracts improves metabolic profile and liver steatosis by the modulation of gut microbiota and hepatic mir‐122 and mir‐34a expression in mice 442
Metabolic-associated fatty liver disease (MAFLD) in coeliac disease 202
A holistic evaluation of patients with chronic Hepatitis D virus (HDV) infection enrolled in the Italian PITER-B and delta cohort 178
Anti-HDV reflex testing in HBsAg-positive subjects: An efficacious strategy to identify HDV infection 167
Clinical features and comorbidity pattern of HCV infected migrants compared to native patients in care in Italy: A real-life evaluation of the PITER cohort 160
Trends in chronic hepatitis B virus infection in Italy over a 10-year period: Clues from the nationwide PITER and MASTER cohorts toward elimination 154
Beneficial Effects of Silybin Treatment After Viral Eradication in Patients With HCV-Related Advanced Chronic Liver Disease: A Pilot Study 144
Pattern of macrovascular invasion in hepatocellular carcinoma 142
Use of Telemedicine for chronic liver disease at a single care center during the COVID-19 pandemic: Prospective observational study 141
Characteristics and survival of patients with primary biliary cholangitis and hepatocellular carcinoma 140
Direct-acting antivirals and hepatocellular carcinoma in chronic hepatitis C: A few lights and many shadows 137
Potential feasibility of atezolizumab-bevacizumab therapy in patients with hepatocellular carcinoma treated with tyrosine-kinase inhibitors 135
Enhanced liver fibrosis score as a noninvasive biomarker in hepatitis C virus patients after direct-acting antiviral agents 134
Laser ablation is superior to TACE in large-sized hepatocellular carcinoma: A pilot case-control study 134
Berberis aristata, elaeis guineensis and coffea canephora extracts modulate the insulin receptor expression and improve hepatic steatosis in NAFLD patients: A pilot clinical trial 133
Effectiveness of Hepatitis B Vaccination Campaign in Italy: Towards the Control of HBV Infection for the First Time in a European Country 131
Non-invasive assessment of portal hypertension in patients with primary biliary cholangitis is affected by severity of cholestasis 128
Risk stratification of HCC occurrence after HCV eradication: a complicate plot of risk factors related and unrelated to the previous viral disease 127
Evaluation of the Effect Derived from Silybin with Vitamin D and Vitamin E Administration on Clinical, Metabolic, Endothelial Dysfunction, Oxidative Stress Parameters, and Serological Worsening Markers in Nonalcoholic Fatty Liver Disease Patients 121
Visceral Obesity and Cytokeratin-18 Antigens as Early Biomarkers of Liver Damage 119
COVID-19 in liver transplant recipients: incidence, hospitalization and outcome in an Italian prospective double-centre study 118
Characteristics and outcome of anti-hepatitis D virus positive patients with hepatocellular carcinoma 117
Humoral Response to 2-dose BNT162b2 mRNA COVID-19 Vaccination in Liver Transplant Recipients 116
Coffee Restores Expression of lncRNAs Involved in Steatosis and Fibrosis in a Mouse Model of NAFLD 116
Acute Delta Hepatitis in Italy spanning three decades (1991-2019): Evidence for the effectiveness of the hepatitis B vaccination campaign 116
Relevance of Bile Acids in Cholangiocarcinoma Pathogenesis: Critical Revision and Future Directions 115
The interpretation of liver function tests in pregnancy 114
Safety and Immunogenicity of Anti-SARS-CoV-2 Booster Dose in Patients with Chronic Liver Disease 108
Impact of SARS-CoV-2 Pandemic on the Management of Patients with Hepatocellular Carcinoma 108
COVID-19 and Fatty Liver Disorders 104
The unhealthy lifestyle in primary biliary cholangitis: An enemy to fight 102
Ribociclib in newly diagnosed hepatitis B infection: A case report 95
Prediction of Clinical Trajectory in HCV-Related ACLD after SVR: Role of Liver Stiffness in a 5-Years Prospective Study 95
The Role of Hepatitis Viruses as Drivers of Hepatocancerogenesis 93
Role of sex in liver tumor occurrence and clinical outcomes: a comprehensive review 92
Sarcopenia in chronic advanced liver diseases: A sex-oriented analysis of the literature 74
Gender and Autoimmune Liver Diseases: Relevant Aspects in Clinical Practice 65
Vascular liver diseases: A sex-oriented analysis of the literature 61
Effectiveness of SARS-CoV-2 vaccination in liver transplanted patients: The debate is open! 60
Refined classification and phenotype-driven analysis of PIEZO1 variants in hereditary red cell and iron disorders 8
Uncovering hidden HCV infections in adults over 55: reflex testing and insights for opportunistic screening in a tertiary care setting 6
Akkermansia muciniphila and HCC: A Gut Feeling 4
Totale 5.056
Categoria #
all - tutte 15.156
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.156


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202255 0 0 0 0 0 0 1 1 0 8 22 23
2022/2023130 9 2 4 6 25 11 6 2 10 40 12 3
2023/2024216 5 59 39 18 5 9 3 23 3 15 22 15
2024/20251.318 55 47 2 23 40 70 126 103 98 124 532 98
2025/20262.805 261 342 325 305 451 115 302 167 256 150 55 76
2026/2027473 439 34 0 0 0 0 0 0 0 0 0 0
Totale 5.056